MedWatch

Zealand Pharma sells shares for over USD 100m

With a 5% discount, the biotech company managed to sell 4,975,000 of its own shares in a direct issuance.

Photo: Zealand Pharma / PR

On Tuesday, Zealand Pharma completed a direct share issue, which was announced on the same day, according to a stock exchange notification.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs